| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical features and risk factors of severely and critically ill patients with COVID-19
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xin Chu, Gui-Fang Zhang, Yong-Ke Zheng, Yi-Gang Zhong, Li Wen, Ping Zeng, Chun-Yi Fu, Xun-Liang Tong, Yun-Fei Long, Jing Li, Ya-Lin Liu, Zhi-Gang Chang and Huan Xi |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Disciplines Construction Project of Peking Union Medical College |
201920202102 |
|
| Corresponding Author |
Huan Xi, MD, Doctor, Doctor, Department of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 Dahua Road, Dong Dan, Beijing 100730, China. xih@bjhmoh.cn |
| Key Words |
COVID-19; SARS-CoV-2; Critically ill; Risk factors; Aspartate transaminase; Amino-terminal pro-brain natriuretic peptide; Creatinine; Calcium |
| Core Tip |
Here, we conducted a case-control study and found out that early drug treatment is an important measure in the treatment of patients with coronavirus disease 2019 (COVID-19). And the following indicators can help clinicians identify patients with severe COVID-19 at an early stage: an elevated neutrophil-to-lymphocyte ratio; elevated aspartate transaminase, N-terminal pro b-type natriuretic peptide, and creatinine levels; as well as decreased serum calcium level. |
| Publish Date |
2022-01-15 12:57 |
| Citation |
Chu X, Zhang GF, Zheng YK, Zhong YG, Wen L, Zeng P, Fu CY, Tong XL, Long YF, Li J, Liu YL, Chang ZG, Xi H. Clinical features and risk factors of severely and critically ill patients with coronavirus disease 2019. World J Clin Cases 2022; 10(3): 840-855 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i3/840.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i3.840 |
